<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-13</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-13</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>172</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
è…¾è®¯å¼€å‘ç”¨äºå°†å•ç»†èƒè½¬å½•ç»„ç¿»è¯‘æˆè›‹ç™½è´¨ç»„çš„é¢„è®­ç»ƒå¤§å‹ç”Ÿæˆæ¨¡å‹ï¼›mRNAç–«è‹—åœ¨æ²»ç–—ç™Œç—‡æ–¹é¢å±•ç°å‡ºæœ‰æœ›å¤§å¹…æå‡ä¸‰å¹´ç”Ÿå­˜ç‡çš„æ½œåŠ›ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ°¨åŸºé…¸ä»£è°¢ï¼ˆç‰¹åˆ«æ˜¯ç»„æ°¨é…¸ã€è°·æ°¨é…°èƒºä»£è°¢ï¼‰å¯¹è‚¿ç˜¤å…ç–«æŠ‘åˆ¶ä¸æ²»ç–—ç–—æ•ˆçš„å½±å“ã€‚<br />
- è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒçš„è§£æï¼Œèšç„¦å®«é¢ˆç™Œã€è‚ç™Œï¼Œç»“åˆå•ç»†èƒä¸ç©ºé—´è½¬å½•ç»„å­¦ã€‚<br />
- æ¢ç´¢è‚¿ç˜¤å…ç–«é€ƒé€¸æœºåˆ¶ï¼ŒåŒ…æ‹¬ç¥ç»ä»‹å¯¼çš„è·¨å™¨å®˜é€šè®¯å’Œé“æ­»äº¡ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åŸºäºå•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦è¿›è¡Œè‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒçš„æ·±å…¥æ¢ç´¢ã€‚<br />
- åˆ©ç”¨å¤§å‹ç”Ÿæˆæ¨¡å‹å®ç°å•ç»†èƒè½¬å½•ç»„åˆ°è›‹ç™½è´¨ç»„çš„ç¿»è¯‘ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ­ç¤ºAKAP95é€šè¿‡ç›¸åˆ†ç¦»è°ƒæ§MLLèåˆé©±åŠ¨çš„è‡´ç™Œè½¬å½•ï¼Œä¸ºç™½è¡€ç—…æ²»ç–—æä¾›æ–°é¶ç‚¹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç™Œç—‡è½¬å½•è°ƒæ§æœºåˆ¶ç ”ç©¶ï¼ˆå¦‚MLLrç™½è¡€ç—…ï¼‰<br />
- ç¥ç»é€€è¡Œæ€§ç–¾ç—…ï¼ˆå¸•é‡‘æ£®ç—…ï¼‰çš„è‚ é“èŒç¾¤å¹²é¢„<br />
- æ€¥æ€§é«“ç³»ç™½è¡€ç—…ï¼ˆAMLï¼‰çš„é¶å‘æ²»ç–—ç­–ç•¥ï¼ˆCDK4/6æŠ‘åˆ¶å‰‚è”åˆç»´å¥ˆæ‰˜å…‹ï¼‰</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- CLIP-Seqã€ChIP-Seqã€RNA-Seqã€PRO-Seqç­‰å¤šç»„å­¦æŠ€æœ¯è”ç”¨ï¼Œæ·±å…¥è§£æåˆ†å­è°ƒæ§æœºåˆ¶ã€‚<br />
- CRISPR/Casç¼–è¾‘æŠ€æœ¯ç”¨äºå¯ç¼–ç¨‹çš„æŸ“è‰²è´¨ä¿®é¥°ç ”ç©¶ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
*   æ–°å‹ç¯çŠ¶ RNA ç¼–ç è›‹ç™½ cPFKFB4 å¢å¼ºèƒ°è…ºç™Œè‘¡è„ç³–ä»£è°¢ï¼Œä¿ƒè¿›ç¼ºæ°§ä¸‹è¿›å±•ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   è¯„ä¼°å¶é…¸å—ä½“ Î± (FRÎ±) ç–«è‹—åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­çš„å®‰å…¨æ€§å’Œå…ç–«åŸæ€§ï¼Œæ¢ç´¢ç®€åŒ–å‰‚é‡ç­–ç•¥ã€‚<br />
*   æ­ç¤º USP20 é©±åŠ¨çš„èƒ†å›ºé†‡ä»£è°¢ä¸ç‚ç—‡ä¿¡å·ä¼ å¯¼ã€èƒ°è…ºç™Œæ¶æ€§è¿›å±•å’ŒåŸºè´¨å…±åŒè¿›åŒ–çš„è”ç³»ã€‚<br />
*   é˜æ˜è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒäº§ç”Ÿ PGE2 å¯¼è‡´ CD8+ T ç»†èƒè€—ç«­ï¼Œé©±åŠ¨ç»“ç›´è‚ ç™Œå¯¹ PD-L1 é˜»æ–­æ²»ç–—è€è¯ã€‚<br />
*   ç ”ç©¶æ–°å‹ circRNA ç¼–ç è›‹ç™½ cPFKFB4 åœ¨èƒ°è…ºç™Œç¼ºæ°§ç¯å¢ƒä¸‹çš„è‘¡è„ç³–ä»£è°¢é‡ç¼–ç¨‹å’Œè¿›å±•ä½œç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   æ•´åˆå¤šç»„å­¦æ•°æ®ï¼ˆä¸´åºŠé˜Ÿåˆ—ã€ç±»å™¨å®˜ã€æœ¬åœŸæ¨¡å‹ï¼‰æ­ç¤º PDAC ç‚ç—‡ä¸ä»£è°¢çš„ä¸²æ‰°ã€‚<br />
*   åˆ©ç”¨ç¼ºæ°§åŸ¹å…»ç³»ç»Ÿç­›é€‰ç¼ºæ°§ååº”æ€§ circRNAï¼Œå¹¶ç ”ç©¶å…¶ç¼–ç è›‹ç™½åŠŸèƒ½ã€‚</p>
<h3>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
"Computo"æœŸåˆŠçš„æ¨å‡ºæ ‡å¿—ç€ç»Ÿè®¡ä¸æœºå™¨å­¦ä¹ é¢†åŸŸå¯¹å¯å¤ç°ç ”ç©¶çš„é‡è§†æå‡ï¼›R Shiny BDDæµ‹è¯•å¼•å…¥äº†â€œGivenâ€æ­¥éª¤ï¼Œç®€åŒ–äº†å‰ç½®æ¡ä»¶è®¾ç½®ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç»Ÿè®¡ä¸æœºå™¨å­¦ä¹ æ–¹æ³•è®ºã€è®¡ç®—åŠç®—æ³•ç ”ç©¶<br />
- Rè¯­è¨€åœ¨PythonåŒ…å¼€å‘ä¸­çš„åº”ç”¨ç»éªŒåˆ†äº«<br />
- æ–°å‹æ±‚èŒå¸‚åœºæ•°æ®æºçš„è¯„ä¼°ä¸åˆ†æ<br />
- Rå’ŒAIæ•°æ®ç§‘å­¦è¯¾ç¨‹çš„å…è´¹å­¦ä¹ æœºä¼š</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- Maestro 0.7.0å¼•å…¥æ¡ä»¶åŒ–ç®¡é“æ‰§è¡Œï¼Œå¢å¼ºDAGæµç¨‹çš„çµæ´»æ€§ã€‚<br />
- R Shiny BDDæµ‹è¯•é€šè¿‡ä¾èµ–æ³¨å…¥å’Œæµ‹è¯•æ›¿èº«ï¼Œå®ç°æ›´å¯é çš„æµ‹è¯•å‰ç½®æ¡ä»¶è®¾ç½®ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç§‘å­¦å®¶åˆ©ç”¨RNAæµ‹åºè¯†åˆ«å‡ºç”¨äºè¯Šæ–­è‚ºå¤–ç»“æ ¸çš„å…ç–«ç”Ÿç‰©æ ‡å¿—ç‰©ï¼›æ–°å‹è®¡ç®—æ¡†æ¶SegPoreæ˜¾è‘—æé«˜äº†çº³ç±³å­”ä¿¡å·RNAä¿®é¥°æ£€æµ‹çš„å‡†ç¡®æ€§ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>ç”Ÿå‘½ç§‘å­¦ä¸åŒ»å­¦</strong>ï¼šåˆ©ç”¨RNAæµ‹åºåŠ é€Ÿç–¾ç—…è¯Šæ–­ï¼ˆç»“æ ¸ç—…ã€èšŠåª’ç—…æ¯’ï¼‰ï¼Œå¼€å‘é¢„æµ‹æŠ—æŠ‘éƒè¯ç‰©ç–—æ•ˆçš„DNAæ£€æµ‹ï¼Œå‘ç°å‡ç¼“é˜¿å°”èŒ¨æµ·é»˜ç—…è¿›å±•çš„è„‘ç»†èƒï¼Œä»¥åŠåˆ©ç”¨å¹²ç»†èƒä¿®å¤è„ŠæŸ±éª¨æŠ˜ã€‚<br />
- <strong>ç‰©ç†ä¸å¤©æ–‡å­¦</strong>ï¼šè¯æ˜å®‡å®™å¹¶éæ¨¡æ‹Ÿï¼Œå‘ç°å¯èƒ½é¢ è¦†é‡å­æŠ€æœ¯çš„å¥‡å¼‚æ™¶ä½“ï¼Œä»¥åŠåˆ©ç”¨CERNåˆ›é€ çš„â€œç«çƒâ€æ¨¡æ‹Ÿå®‡å®™æ—©æœŸç°è±¡ã€‚<br />
- <strong>ç¯å¢ƒä¸ç”Ÿç‰©å­¦</strong>ï¼šæ­ç¤ºå¤§é™†æ¿å—ä»ä¸‹æ–¹å‰¥ç¦»é©±åŠ¨æµ·æ´‹ç«å±±æ´»åŠ¨ï¼Œæ¢ç©¶å†œè¯å¯¹é›„æ€§ç”Ÿæ®–å¥åº·çš„æ½œåœ¨å½±å“ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>RNAæµ‹åº</strong>ï¼šåœ¨ç–¾ç—…è¯Šæ–­å’Œç—…æ¯’ç ”ç©¶ä¸­å‘æŒ¥å…³é”®ä½œç”¨ã€‚<br />
- <strong>è®¡ç®—ç”Ÿç‰©å­¦</strong>ï¼šSegPoreæ¡†æ¶æå‡äº†RNAä¿®é¥°æ£€æµ‹ç²¾åº¦ã€‚<br />
- <strong>ææ–™ç§‘å­¦</strong>ï¼šå¼€å‘é«˜æ•ˆå¾®å‹æ¿€å…‰å™¨å’Œå¯ä¿®å¤ç‰™é‡‰è´¨çš„ç”Ÿç‰©ææ–™ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (54æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>å®«é¢ˆç™Œæˆçº¤ç»´ç»†èƒçš„è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè§£æï¼šåŸºäºå•ç»†èƒä¸ç©ºé—´è½¬å½•ç»„å­¦çš„æ·±å…¥æ¢ç´¢</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä½œå›¾ä¸«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€å•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€ç©ºé—´ç»„å­¦ã€è½¬å½•ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæœ€è¿‘æœ‰å°ä¼™ä¼´åæ˜ æ”¶ä¸åˆ°æ¨é€ï¼Œå› ä¸ºå…¬ä¼—å·æ”¹äº†æ¨é€ç®—æ³•ï¼Œç°åœ¨éœ€è¦åŠ æ˜Ÿæ ‡ï¼Œå¤šç‚¹èµã€ç‚¹åœ¨çœ‹ï¼Œæ‰èƒ½å‡†æ—¶æ”¶åˆ°æ¨é€å“¦ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523399&amp;idx=1&amp;sn=3c7a3a899361e9207867c634f747ac15" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>CancerSCEM - ç™Œç—‡å•ç»†èƒè¡¨è¾¾å›¾è°±ã€å›½å®¶ç”Ÿç‰©ä¿¡æ¯ä¸­å¿ƒã€‘</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡èœé¸Ÿå›¢<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€cancerã€å•ç»†èƒã€ç”Ÿç‰©ä¿¡æ¯ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç™Œç—‡å•ç»†èƒè¡¨è¾¾å›¾è°±ï¼ˆCancer Single-cell Expression Mapï¼‰ï¼ˆhttps://ng<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247538000&amp;idx=1&amp;sn=4908ae14f38d2065eaf2db6dd57dbeb3" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>åˆä¸€ç¯‡æ°¨åŸºé…¸ä»£è°¢ç”Ÿä¿¡ã€‚æœ¬æ–‡èšç„¦ç»„æ°¨é…¸ä»£è°¢å¯¹è‚¿ç˜¤å…ç–«çš„æŠ‘åˆ¶ä½œç”¨ï¼Œç»“åˆå®éªŒéªŒè¯ã€‚æ˜¯ä¸€ç¯‡å¹²æ¹¿ç»“åˆçš„å¥½æ–‡ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€ä»£è°¢ã€ä»£è°¢ç»„ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503943&amp;idx=4&amp;sn=82b312ddfdc23f2b9a900906c4305558" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>Nat Biomed Eng | è…¾è®¯å¼€å‘ç”¨äºå°†å•ç»†èƒè½¬å½•ç»„ç¿»è¯‘æˆè›‹ç™½è´¨ç»„çš„é¢„è®­ç»ƒå¤§å‹ç”Ÿæˆæ¨¡å‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šäººä½“è›‹ç™½è´¨ç»„å¯¼èˆªè®¡åˆ’<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€å•ç»†èƒã€è½¬å½•ç»„ã€è›‹ç™½è´¨ç»„ã€ç»„è›‹ç™½<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506980&amp;idx=3&amp;sn=47594ae9ca6523cd74a6d5fd11d40429" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>åˆšåˆšå‘è¡¨7.5åˆ†ç”Ÿä¿¡ï¼Œèšç„¦æ–°çƒ­ç‚¹æ£•æ¦ˆé…°åŒ–ï¼Œå•ç»†èƒ+æ— ç›‘ç£èšç±»+ç™¾ç§æœºå™¨å­¦ä¹ +ç®€å•éªŒè¯ã€‚éè‚¿ç˜¤ç”Ÿä¿¡æ¨¡æ¿ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡ã€èšç±»<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493004&amp;idx=1&amp;sn=c755b1efd4051bb073d5a927fd8df30c" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>å•ç»†èƒè½¬å½•ç»„ç»˜åˆ¶MASHå‘è‚ç™Œè½¬åŒ–å…ç–«å¾®ç¯å¢ƒå…¨æ™¯å›¾è°±</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€å•ç»†èƒã€è½¬å½•ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæ–‡ç« ç®€ä»‹åŠèƒŒæ™¯ä»‹ç» å•ç»†èƒæµ‹åºæ•°æ®ç®€ä»‹ ä¸»è¦åˆ†æç»“æœæ¦‚è¿°<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533603&amp;idx=1&amp;sn=a39eea4ed83b152b5b7725efa3b06d85" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>IF 25+ |å± å‘¦å‘¦å›¢é˜Ÿåˆ©ç”¨å•ç»†èƒæµ‹åºå‘ç°é’è’¿ç´ å…ç–«è°ƒèŠ‚æ–°æœºåˆ¶ï¼Œç”Ÿä¿¡å¼€æºä»£ç å­¦ä¹ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡é’±åŒå­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€æµ‹åºã€å•ç»†èƒã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå¥½çš„å•ç»†èƒç”Ÿä¿¡ä»£ç å­¦ä¹ <br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495519&amp;idx=1&amp;sn=72415374acd7a019b7ca977842dfa56e" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>èšç„¦æ°¨åŸºé…¸ä»£è°¢çƒ­ç‚¹ï¼Œç»“åˆç™¾ç§æœºå™¨å­¦ä¹ +å•ç»†èƒ+Scissor +å…ç–«æ²»ç–—+è¡¨è¾¾éªŒè¯ï¼Œä¸€ç¯‡2åŒºæ–‡ç« å°±åˆ°æ‰‹äº†ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€ä»£è°¢ã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503943&amp;idx=5&amp;sn=a87da62c71c09393ebcb3bdd2fb99591" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>æ°¨åŸºé…¸ä»£è°¢çƒ­åº¦ä¸å‡ï¼šæœ€æ–°ç”Ÿä¿¡å‘æ–‡ï¼Œé¶å‘è°·æ°¨é…°èƒºä»£è°¢å¢åŠ å…ç–«æ²»ç–—ç–—æ•ˆï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€ä»£è°¢ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503943&amp;idx=1&amp;sn=be30928f95d3cdab93bc3f1aaabd0a20" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>è‚¿ç˜¤ç¼©å°è¶…å…«æˆï¼æ–°ç ”ç©¶å‘ç°æœ‰æœ›æ”»å…‹ç™Œç—‡è€è¯çš„ERKæŠ‘åˆ¶å‰‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå­¦æœ¯ç»çº¬<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç™Œç—‡ã€è€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæœ‰æœ›å…‹æœè·å¾—æ€§è€è¯<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568668&amp;idx=2&amp;sn=106543c71c87f90806c9289b22d18171" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 44 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (45æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE271855 Phase separation mediates AKAP95 regulating oncogenic MLL-fusion driven transcription and its application in leukemia therapy (CLIP-Seq)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bi Shi ; Yongkun Luan ; Hao Jiang ; Wei LiSeries Type : OtherOrganism : Homo sapiensOncogenic transcription represents a crucial event in MLL rearranged (MLLr) leukemia, yet the precise role of transcription co-activators in MLL-fusion protein-associated transcription and their contribution to leukemogenesis remain incompletely understood. Here, we demonstrate that AKAP95 is notably up-regulated in both MLLr patients and in MLL-AF9-transformed mouse bone marrow. AKAP95 proves essential for initiating mouse MLL-AF9 leukemia, exhibiting widespread DNA binding across the genome, particularly at gene promoters. Interaction with the translocated MLL1 fragment primarily occurs through phase separation mechanisms. AKAP95's RNA-binding properties, coupled with its phase separation behavior, govern its binding to pre-mRNA and concurrent transcriptional regulation. Importantly, we engineered a peptide to disrupt its phase separation, effectively attenuating AKAP95-mediated transcriptional co-activation and inhibiting the growth of MLLr cell lines. These findings illustrate a vivid example of an RNA-binding protein orchestrating transcription and tumorigenesis via phase separation, underscoring the potential for targeting oncogenic condensation mechanisms therapeutically.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271855" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE271854 Phase separation mediates AKAP95 regulating oncogenic MLL-fusion driven transcription and its application in leukemia therapy (ChIP-Seq)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bi Shi ; Yongkun Luan ; Hao Jiang ; Wei LiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensOncogenic transcription represents a crucial event in MLL rearranged (MLLr) leukemia, yet the precise role of transcription co-activators in MLL-fusion protein-associated transcription and their contribution to leukemogenesis remain incompletely understood. Here, we demonstrate that AKAP95 is notably up-regulated in both MLLr patients and in MLL-AF9-transformed mouse bone marrow. AKAP95 proves essential for initiating mouse MLL-AF9 leukemia, exhibiting widespread DNA binding across the genome, particularly at gene promoters. Interaction with the translocated MLL1 fragment primarily occurs through phase separation mechanisms. AKAP95's RNA-binding properties, coupled with its phase separation behavior, govern its binding to pre-mRNA and concurrent transcriptional regulation. Importantly, we engineered a peptide to disrupt its phase separation, effectively attenuating AKAP95-mediated transcriptional co-activation and inhibiting the growth of MLLr cell lines. These findings illustrate a vivid example of an RNA-binding protein orchestrating transcription and tumorigenesis via phase separation, underscoring the potential for targeting oncogenic condensation mechanisms therapeutically.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271854" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE271857 Phase separation mediates AKAP95 regulating oncogenic MLL-fusion driven transcription and its application in leukemia therapy (RNA-Seq)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bi Shi ; Yongkun Luan ; Hao Jiang ; Wei LiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Mus musculusOncogenic transcription represents a crucial event in MLL rearranged (MLLr) leukemia, yet the precise role of transcription co-activators in MLL-fusion protein-associated transcription and their contribution to leukemogenesis remain incompletely understood. Here, we demonstrate that AKAP95 is notably up-regulated in both MLLr patients and in MLL-AF9-transformed mouse bone marrow. AKAP95 proves essential for initiating mouse MLL-AF9 leukemia, exhibiting widespread DNA binding across the genome, particularly at gene promoters. Interaction with the translocated MLL1 fragment primarily occurs through phase separation mechanisms. AKAP95's RNA-binding properties, coupled with its phase separation behavior, govern its binding to pre-mRNA and concurrent transcriptional regulation. Importantly, we engineered a peptide to disrupt its phase separation, effectively attenuating AKAP95-mediated transcriptional co-activation and inhibiting the growth of MLLr cell lines. These findings illustrate a vivid example of an RNA-binding protein orchestrating transcription and tumorigenesis via phase separation, underscoring the potential for targeting oncogenic condensation mechanisms therapeutically.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271857" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE271856 Phase separation mediates AKAP95 regulating oncogenic MLL-fusion driven transcription and its application in leukemia therapy (PRO-Seq)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bi Shi ; Yongkun Luan ; Hao Jiang ; Wei LiSeries Type : OtherOrganism : Homo sapiensOncogenic transcription represents a crucial event in MLL rearranged (MLLr) leukemia, yet the precise role of transcription co-activators in MLL-fusion protein-associated transcription and their contribution to leukemogenesis remain incompletely understood. Here, we demonstrate that AKAP95 is notably up-regulated in both MLLr patients and in MLL-AF9-transformed mouse bone marrow. AKAP95 proves essential for initiating mouse MLL-AF9 leukemia, exhibiting widespread DNA binding across the genome, particularly at gene promoters. Interaction with the translocated MLL1 fragment primarily occurs through phase separation mechanisms. AKAP95's RNA-binding properties, coupled with its phase separation behavior, govern its binding to pre-mRNA and concurrent transcriptional regulation. Importantly, we engineered a peptide to disrupt its phase separation, effectively attenuating AKAP95-mediated transcriptional co-activation and inhibiting the growth of MLLr cell lines. These findings illustrate a vivid example of an RNA-binding protein orchestrating transcription and tumorigenesis via phase separation, underscoring the potential for targeting oncogenic condensation mechanisms therapeutically.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271856" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE296011 è¡¥å……çŸ­é“¾è„‚è‚ªé…¸å’Œç›Šç”Ÿå…ƒå¯æ”¹å–„å¸•é‡‘æ£®ç—…æ‚£è€…çš„ä¸´åºŠç»“æœï¼šä¸€é¡¹éšæœºåŒç›²å‰ç»æ€§ç ”ç©¶ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€metabolismã€metabolicã€metabolomeã€metabolomicsã€cardiacã€gliomaã€kinaseã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tobias Hegelmaier ; Alexander Duscha ; Christiane Desel ; Sabrina Fuchs ; Michal Shapira ; Sivan Amidror ; Qihao Shan ; Gabriele I Stangl ; Frank Hirche ; Stefan Kempa ; AndrÃ¡s Maifeld ; Lisa-Marie WÃ¼rtele ; Jana Peplinski ; Diana Jauk ; Gitali Naim ; Nuphar Shidlovsky ; Adva Cohen ; Yifat Bennet ; Lisa Paschold ; Claudia A Dumitru ; Ute ObermÃ¼ller-Jevic ; Svein-Olaf Hustvedt ; Nina Timmesfeld ; Ralf Gold ; Antonia Zapf ; Mascha Binder ; Ibrahim E Sandalcioglu ; Sanaz Mostaghim ; Horst Przuntek ; Eran Segal ; Nissan Yissachar ; Aiden HaghikiaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground: Parkinsonâ€™s disease is associated with a dysbiotic, proinflammatory gut microbiome, disruptions to intestinal barrier functions, and immunological imbalance. Microbiota-produced short-chain fatty acids, such as propionic and butyric acid promote gut barrier integrity and immune regulation, but their impact on Parkinsonâ€™s disease pathology remains mostly unknown .Methods: In a randomized double-blind prospective study, 72 people with Parkinsonâ€™s disease received propionic and butyric acid and/or the prebiotic fiber 2â€²-fucosyllactose supplementation over 6 months in combination with existing Parkinsonâ€™s disease-specific therapy. Patients underwent complete neurological assessment and provided blood and stool samples before as well as 3 and 6 months after supplementation. Results: We observed improvement in motor and nonmotor symptoms, in addition to modulation of peripheral immunity and improved mitochondrial respiration in immunocytes. Postintervention microbiota remodeled inflammatory and barrier-related gene sets in gut organ cultures and improved in vitro barrier functions. Treatment response was associated with microbiome composition, distinct patterns of colonic transcription and permeability ex vivo. Multiobjective analysis revealed immune parameters associated with an optimal response to supplementation. Conclusion: Short-chain fatty acids ameliorate clinical symptoms in Parkinsonâ€™s disease patients and modulate intestinal and peripheral immunity.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296011" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE291339 CDK4/6 æŠ‘åˆ¶å‰‚ Palbociclib å…‹æœäº† Venetoclax è€è¯æœºåˆ¶ï¼Œå¹¶åœ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­ä¼˜äºå•è¯æ²»ç–— [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€Bioconductorã€Seuratã€Scanpyã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Melissa L Stewart ; Jessica Gibbs ; Andy Kaempf ; Jeffrey W TynerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensVenetoclax (ven) combined with the hypomethylating agent azacytidine (aza) is a widely used therapy for Acute Myeloid Leukemia (AML), however, most patients develop resistance. Using RNASeq, we identified loss of Ikaros (IKZF1) as a potential resistance mechanism to ven+palbo. Examination of cells with IKZF1-loss revealed upregulation of the receptor, AXL, with concordant AXL inhibitor sensitivity in AML tumors harboring IKZF1 mutations. This work suggests that the combination of ven+palbo is a potential novel therapy for AML for potential subpopulations that may benefit the most from this treatment, as well as targeting translation as a means to overcome ven resistance.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291339" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE291338 CDK4/6 æŠ‘åˆ¶å‰‚ Palbociclib å…‹æœäº† Venetoclax è€è¯æœºåˆ¶ï¼Œå¹¶åœ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­ä¼˜äºå•è¯æ²»ç–— [CRISPR ç­›é€‰]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€Bioconductorã€Seuratã€Scanpyã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Melissa L Stewart ; Jessica Gibbs ; Daniel Bottomly ; Shannon K McWeeney ; Jeffrey W TynerSeries Type : OtherOrganism : Homo sapiensVenetoclax (ven) combined with the hypomethylating agent azacytidine (aza) is a widely used therapy for Acute Myeloid Leukemia (AML), however, most patients develop resistance. A genome-wide CRISPR screen showed that loss of genes involved in translation conferred sensitivity to ven but not ven+palbo. Accordingly, we show that increased translation occurs after AML cells are challenged with ven, and ven+palbo blocks this increase. We also found that loss of BAX, which leads to ven resistance, was overcome by combination with CDK4/6 inhibitors. Conversely, loss of RB1, a known mechanism of resistance to CDK4/6 inhibitors, was mitigated by ven+palbo. This work suggests that the combination of ven+palbo is a potential novel therapy for AML for potential subpopulations that may benefit the most from this treatment, as well as targeting translation as a means to overcome ven resistance.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291338" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE271858 Phase separation mediates AKAP95 regulating oncogenic MLL-fusion driven transcription and its application in leukemia therapy</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€immuneã€immunityã€TMEã€vaccineã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bi Shi ; Yongkun Luan ; Hao Jiang ; Wei LiSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencing ; OtherOrganism : Homo sapiens ; Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271858" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE296010 è¡¥å……çŸ­é“¾è„‚è‚ªé…¸å’Œç›Šç”Ÿå…ƒå¯æ”¹å–„å¸•é‡‘æ£®ç—…æ‚£è€…çš„ä¸´åºŠç–—æ•ˆï¼šä¸€é¡¹éšæœºåŒç›²å‰ç»æ€§ç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€metabolismã€metabolicã€metabolomeã€metabolomicsã€cardiacã€gliomaã€kinaseã€DepMapã€depmapã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tobias Hegelmaier ; Alexander Duscha ; Christiane Desel ; Sabrina Fuchs ; Michal Shapira ; Sivan Amidror ; Qihao Shan ; Gabriele I Stangl ; Frank Hirche ; Stefan Kempa ; AndrÃ¡s Maifeld ; Lisa-Marie WÃ¼rtele ; Jana Peplinski ; Diana Jauk ; Gitali Naim ; Nuphar Shidlovsky ; Adva Cohen ; Yifat Bennet ; Lisa Paschold ; Claudia A Dumitru ; Ute ObermÃ¼ller-Jevic ; Svein-Olaf Hustvedt ; Nina Timmesfeld ; Ralf Gold ; Antonia Zapf ; Mascha Binder ; Ibrahim E Sandalcioglu ; Sanaz Mostaghim ; Horst Przuntek ; Eran Segal ; Nissan Yissachar ; Aiden HaghikiaSeries Type : OtherOrganism : feces metagenomeBackground: Parkinsonâ€™s disease is associated with a dysbiotic, proinflammatory gut microbiome, disruptions to intestinal barrier functions, and immunological imbalance. Microbiota-produced short-chain fatty acids, such as propionic and butyric acid promote gut barrier integrity and immune regulation, but their impact on Parkinsonâ€™s disease pathology remains mostly unknown .Methods: In a randomized double-blind prospective study, 72 people with Parkinsonâ€™s disease received propionic and butyric acid and/or the prebiotic fiber 2â€²-fucosyllactose supplementation over 6 months in combination with existing Parkinsonâ€™s disease-specific therapy. Patients underwent complete neurological assessment and provided blood and stool samples before as well as 3 and 6 months after supplementation. Results: We observed improvement in motor and nonmotor symptoms, in addition to modulation of peripheral immunity and improved mitochondrial respiration in immunocytes. Postintervention microbiota remodeled inflammatory and barrier-related gene sets in gut organ cultures and improved in vitro barrier functions. Treatment response was associated with microbiome composition, distinct patterns of colonic transcription and permeability ex vivo. Multiobjective analysis revealed immune parameters associated with an optimal response to supplementation. Conclusion: Short-chain fatty acids ameliorate clinical symptoms in Parkinsonâ€™s disease patients and modulate intestinal and peripheral immunity.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296010" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE305304 å°åˆ†å­æŠ‘åˆ¶å‰‚ MuRF1 å¯é¢„é˜²æ—©æœŸåºŸç”¨æ€§è†ˆè‚ŒåŠŸèƒ½éšœç¢å’Œèç¼©ï¼šæ½œåœ¨çš„ç»†èƒå’Œåˆ†å­æœºåˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€lymphomaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€epigenomeã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Fernando Ribeiro ; Paulo R Jannig ; Siegfried Labeit ; Anselmo S MoriscotSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusBackground: Disuse-induced diaphragmatic dysfunction and atrophy (DIDD) is characterized by a rapid and progressive loss of diaphragm muscle fibers size and contractile function. Patients undergoing mechanical ventilation or diaphragm paralysis can develop DIDD, which correlates with worse clinical outcomes, morbidity and mortality. We hypothesize tha Muscle RING-finger protein-1 (MuRF1) activity plays an important role in DIDD onset and pathophysiology. Aim: To evaluate the effect of small-molecule inhibition of MuRF1 (MyoMed-205) on early DIDD in an experimental model in rats.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305304" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 35 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (4æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>è¯„ä¼°ä¸¤å‰‚å¶é…¸å—ä½“ Î± ç–«è‹—åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œæ‚£è€…ä¸­çš„å®‰å…¨æ€§å’Œå…ç–«åŸæ€§çš„ II æœŸè¯•éªŒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€ç–«è‹—<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šCD4 T ç»†èƒå…ç–«ä¸æé«˜ä¹³è…ºç™Œæ‚£è€…çš„ç”Ÿå­˜ç‡æœ‰å…³ã€‚æˆ‘ä»¬ä¹‹å‰æŠ¥é“äº†ä¸€é¡¹è¯„ä¼°å¶é…¸å—ä½“Î±ï¼ˆFRÎ±ï¼‰ç–«è‹—ä¸ç¯ç£·é…°èƒºï¼ˆCPï¼‰ä¸€èµ·ç»™è¯çš„ I æœŸè¯•éªŒï¼Œè¯¥è¯•éªŒæ˜¾ç¤ºå‡ºå‡ºè‰²çš„å®‰å…¨æ€§å’Œå…ç–«åŸæ€§ã€‚ä¸ºäº†ç®€åŒ–ç–«è‹—ç­–ç•¥ä»¥ä½¿å…¶æ˜“äºä½¿ç”¨ï¼Œæˆ‘ä»¬åœ¨æ­¤æŠ¥å‘Šäº†ä¸€é¡¹éšæœº II æœŸè¯•éªŒçš„ç»“æœï¼Œè¯¥è¯•éªŒè¯„ä¼°äº†è¾ƒä½çš„ç–«è‹—å‰‚é‡å’ŒåŸå§‹å‰‚é‡ï¼Œåœ¨æœ‰æˆ–æ²¡æœ‰ç¯ç£·é…°èƒºé¢„å¤„ç†çš„æƒ…å†µä¸‹ç»™è¯ã€‚æ‚£è€…å’Œæ–¹æ³•ï¼šå®Œæˆæ‰€æœ‰å…¨èº«å’Œå±€éƒ¨æ²»ç–—çš„ä¸‰é˜´æ€§ä¹³è…ºç™Œ ï¼ˆTNBCï¼‰ æ‚£è€…è¢«åˆ†é…æ¥å—ä½å‰‚é‡ ï¼ˆ825 mgï¼‰ æˆ–é«˜å‰‚é‡ ï¼ˆ2.5 mgï¼‰ ç–«è‹—è‚½åŠ  GM-CSF åœ¨å…­ä¸ª 4 å‘¨å‘¨æœŸå†…ï¼Œæ¥ç§ç–«è‹—å‰æœ‰æˆ–æ²¡æœ‰ CPã€‚åœ¨ç–«è‹—æ¥ç§å‰åç›‘æµ‹å®‰å…¨æ€§å¹¶è¯„ä¼°å…ç–«åŸæ€§ã€‚ç»“æœï¼šå…± 80 ä¾‹æ‚£è€…æ¥ç§ç–«è‹—ï¼Œ58 ä¾‹æ‚£è€…å…ç–«åŸæ€§å¯è¯„ä¼°ã€‚ç–«è‹—æ¥ç§è€å—æ€§è‰¯å¥½ï¼Œ83% çš„æ‚£è€…äº§ç”Ÿäº†å…ç–«åŠ›ã€‚FRÎ±ç‰¹å¼‚æ€§ T ç»†èƒæ°´å¹³é«˜ã€æŒä¹…ï¼Œä¸æŠ—ç ´ä¼¤é£ç±»æ¯’ç´ çš„ T ç»†èƒæ°´å¹³ç›¸å½“ã€‚ä¸¤ç§å‰‚é‡ä¹‹é—´çš„å…ç–«åŠ›æ²¡æœ‰å·®å¼‚ã€‚CP é¢„å¤„ç†ä¹Ÿä¸å½±å“å…ç–«ååº”ã€‚8<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1988351415817449472/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>USP20 é©±åŠ¨çš„èƒ†å›ºé†‡ä»£è°¢å°†ç‚ç—‡ä¿¡å·ä¼ å¯¼ä¸èƒ°è…ºç™Œçš„æ¶æ€§è‚¿ç˜¤å’ŒåŸºè´¨å…±åŒè¿›åŒ–è”ç³»èµ·æ¥</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç‚ç—‡ä¿¡å·ä¼ å¯¼ã€ä»£è°¢é‡ç¼–ç¨‹å’ŒåŸºè´¨å¤æ‚æ€§å·²æˆä¸ºèƒ°è…ºå¯¼ç®¡è…ºç™Œ ï¼ˆPDACï¼‰ çš„æ ¸å¿ƒæ ‡å¿—ã€‚è¿™äº›ç¨‹åºä¹‹é—´çš„ä¸²æ‰°å¯èƒ½ä»£è¡¨åŒæ—¶æ‰°ä¹±å¤šä¸ªè‚¿ç˜¤ä¿ƒè¿›è¿‡ç¨‹çš„æ½œåœ¨é¶ç‚¹ã€‚é€šè¿‡æ•´åˆæ¥è‡ªä¸´åºŠé˜Ÿåˆ—ã€æ‚£è€…æ¥æºçš„ç±»å™¨å®˜å’Œæœ¬åœŸæ¨¡å‹çš„å¤šç»„å­¦æ•°æ®ï¼Œæˆ‘ä»¬å‘ç° PDAC ä¸­çš„è‚¿ç˜¤å†…æºæ€§ç‚ç—‡çº§è”ååº”æ˜¯ç”²ç¾ŸæˆŠé…¸é€”å¾„åŠ«æŒçš„ä¸»è¦è°ƒèŠ‚å› å­ï¼Œè¿™æ¨åŠ¨äº†æ¶æ€§è¿›å±•å’ŒåŸºè´¨å…±åŒè¿›åŒ–ã€‚TNFSF13B+ è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒæ¿€æ´»è‚¿ç˜¤ä¸Šçš®ç»†èƒä¸­çš„ STAT3 ä¿¡å·ä¼ å¯¼ï¼Œå¯¼è‡´ USP20 çš„è½¬å½•ä¸Šè°ƒã€‚è¿™ç§å»æ³›ç´ é…¶ç¨³å®šäº† HMGCRï¼Œä»¥å¢å¼ºç”²ç¾ŸæˆŠé…¸é€šé‡ï¼Œå¯¼è‡´èƒ†å›ºé†‡å’Œé¦™å¶åŸºé¦™å¶é…°ç„¦ç£·é…¸ç›çš„äº§ç”Ÿè¿‡é‡ã€‚USP20 ä»‹å¯¼çš„ä»£è°¢æ”¹å˜è¯±å¯¼çš„ YAP/TAZ ä¿¡å·ä¼ å¯¼åˆºæ¿€ä¿ƒè¿›è‚¿ç˜¤ç»†èƒå¢æ®–å¹¶è§¦å‘ç™Œç—‡ç›¸å…³æˆçº¤ç»´ç»†èƒ ï¼ˆCAFï¼‰ çš„æ¿€æ´»ã€‚ä½¿ç”¨é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚å¯¹ USP20 è¿›è¡ŒåŸºå› æ¶ˆèæˆ–è¯ç†å­¦æŠ‘åˆ¶å¯é€†è½¬è‚¿ç˜¤ä»£è°¢å¤±è°ƒï¼Œä»è€ŒæŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿å’ŒåŸºè´¨ç»“ç¼”å¢ç”Ÿã€‚æ­¤å¤–ï¼ŒUSP20 æŠ‘åˆ¶ä¸æŠ— PD-1/æŠ— CTLA-4<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986639189233016832/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒäº§ç”Ÿ PGE2 ä»¥ä¿ƒè¿› CD8+ T ç»†èƒè€—ç«­å¹¶é©±åŠ¨å¾®å«æ˜Ÿç¨³å®šç»“ç›´è‚ ç™Œå¯¹ PD-L1 é˜»æ–­çš„è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€è€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­æ²»ç–—å¯¹å¾®å«æ˜Ÿä¸ç¨³å®š ï¼ˆMSIï¼‰ ç»“ç›´è‚ ç™Œ ï¼ˆCRCï¼‰ éå¸¸æœ‰æ•ˆã€‚ç„¶è€Œï¼Œå¾®å«æ˜Ÿç¨³å®š ï¼ˆMSSï¼‰ è‚¿ç˜¤å¯¹å…ç–«æ²»ç–—å…·æœ‰å†…åœ¨çš„è€è¯æ€§ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬è¯•å›¾é€šè¿‡è¡¨å¾ MSS å’Œ MSI è‚¿ç˜¤æ¨¡å‹çš„å…ç–«è°±æ¥æ›´å¥½åœ°äº†è§£ CRC ä¸­æŠ— PD-L1 æ²»ç–—è€è¯çš„æœºåˆ¶ã€‚è™½ç„¶ä¸¤ç§è‚¿ç˜¤ç±»å‹éƒ½è¡¨ç°å‡ºç˜¤å†… CD8+ T ç»†èƒå’Œ PD-L1 è¡¨è¾¾ï¼Œä½†è€—å°½çš„ CD8+ T ç»†èƒè¡¨å‹ä¸åŒã€‚åœ¨ MSS è‚¿ç˜¤ä¸­ï¼Œè€—å°½çš„ CD8 + T ç»†èƒå…±è¡¨è¾¾ PD-1 å’Œ TIGITï¼Œå¹¶è¡¨ç°å‡ºç»ˆæœ«è€—å°½ç‰¹å¾ï¼Œç»†èƒå› å­åˆ†æ³Œä½ï¼Œç»†èƒæ¯’æ€§åŠŸèƒ½æœ‰é™ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼ŒMSI è‚¿ç˜¤ä¸­çš„ PD-1+ CD8+ T ç»†èƒä¸è¡¨è¾¾ TIGITï¼Œè¡¨ç°å‡ºæ›´é«˜çš„ç»†èƒå› å­å’Œç»†èƒæ¯’æ€§æ´»æ€§ã€‚æœ‰è¶£çš„æ˜¯ï¼Œå…ç–«æŠ‘åˆ¶æ€§ M2 æ ·è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒï¼ˆTAMï¼‰åœ¨ MSI è‚¿ç˜¤ä¸­ç§¯ç´¯ï¼Œå¹¶ä¸ PD-1+ TIGIT+ CD8+ T ç»†èƒé¢‘ç‡å‘ˆæ­£ç›¸å…³ã€‚M2 æ · TAM è€—ç«­é™ä½äº† TIGIT<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986639195407032320/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>ä¸€ç§ç”± hsa_circ_0065394 ç¼–ç çš„æ–°å‹è›‹ç™½ cPFKFB4 å¯å¢å¼º PKM2 ä»‹å¯¼çš„è‘¡è„ç³–ä»£è°¢é‡ç¼–ç¨‹ï¼Œä¿ƒè¿›ç¼ºæ°§ä¸‹èƒ°è…ºç™Œè¿›å±•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç¼ºæ°§æ˜¯å®ä½“ç˜¤çš„æ ‡å¿—ï¼Œå¯å¼•èµ·ç™Œç—‡çš„è‘¡è„ç³–ä»£è°¢é‡ç¼–ç¨‹ã€‚ç”±ç¯çŠ¶ RNA ï¼ˆcircRNAï¼‰ ç¼–ç çš„è‚½å’Œè›‹ç™½è´¨è¢«ç¡®å®šä¸ºè‚¿ç˜¤æ¶æ€§è¿›å±•çš„å…³é”®ä»‹è´¨ã€‚å°½ç®¡å¦‚æ­¤ï¼Œèƒ°è…ºç™Œ ï¼ˆPCï¼‰ ä¸­ç¼ºæ°§ç›¸å…³ circRNA ç¼–ç çš„è›‹ç™½è´¨ä»ç„¶æœªè¡¨å¾ä¸”çŸ¥ä¹‹ç”šå°‘ã€‚ä½¿ç”¨ç¼ºæ°§åŸ¹å…»ç³»ç»Ÿç­›é€‰ PC ä¸­ç¼ºæ°§ååº”æ€§ circRNAï¼ˆhsa_circ_0065394ï¼‰ã€‚é‡‡ç”¨ç”Ÿç‰©ä¿¡æ¯å­¦å’Œ RNA å…ç–«æ²‰æ·€ç ”ç©¶äº† hsa_circ_0065394 çš„ç¯åŒ–æœºåˆ¶ã€‚åˆ©ç”¨ qRT-PCR å’ŒåŸä½æ‚äº¤å¯¹ hsa_circ_0065394 åœ¨ PC ä¸­çš„è¡¨è¾¾è°±å’Œæ½œåœ¨ä¸´åºŠæ„ä¹‰è¿›è¡Œè¯„ä¼°ã€‚åŒè§å…‰ç´ é…¶æŠ¥å‘ŠåŸºå› æ£€æµ‹ã€è´¨è°±å’Œè›‹ç™½è´¨å°è¿¹é‰´å®šå‡ºç”± hsa_circ_0065394 ç¼–ç çš„è›‹ç™½ cPFKFB4ã€‚é€šè¿‡ä½“å†…å’Œä½“å¤–åŠŸèƒ½è·å¾—å’Œä¸§å¤±å®éªŒéªŒè¯äº† cPFKFB4 çš„ç”Ÿç‰©å­¦åŠŸèƒ½ã€‚ä»æœºåˆ¶è§’åº¦å‡ºå‘ï¼Œé€šè¿‡è´¨è°±ã€å…ç–«å…±æ²‰æ·€ã€å…ç–«è§å…‰ã€PKM å‰ªæ¥ã€RNA å…ç–«æ²‰æ·€ã€è›‹ç™½è´¨å°è¿¹å’ŒæŠ¢æ•‘å®éªŒç­‰æ–¹æ³•ï¼Œæ¢è®¨äº†<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1988451054084272128/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (8æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨8æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>Computoâ€”â€”ç»Ÿè®¡å­¦å’Œæœºå™¨å­¦ä¹ é¢†åŸŸé€æ˜ä¸”å¯å¤ç°ç ”ç©¶çš„æœŸåˆŠ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€cardiacã€resistanceã€scRNAã€scDNAã€scATACã€spatialã€proteomeã€Seuratã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šComputo is a journal promoting methodological, computational, and algorithmic contributions in statistics and machine learning that provide a better understanding of which models or methods are most appropriate to answer specific scientific questio... Continue reading: Computo â€“ A Journal for Transparent and Reproducible Research in Statistics and Machine Learning<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/computo-a-journal-for-transparent-and-reproducible-research-in-statistics-and-machine-learning/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>R Shiny ä¸­çš„è¡Œä¸ºé©±åŠ¨å¼€å‘ï¼šä½¿ç”¨ç»™å®šæ­¥éª¤è®¾ç½®æµ‹è¯•å‰ææ¡ä»¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šHi-Cã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šLearn how to set up test preconditions in Shiny BDD using Given steps. Master dependency injection, test doubles, and composable setup patterns for reliable R testing. Continue reading: Behavior-Driven Development in R Shiny: Setting Up Test Preconditions with Given Steps<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/behavior-driven-development-in-r-shiny-setting-up-test-preconditions-with-given-steps/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ä¸€äº›æ— ç”¨å´æœ‰ç”¨çš„ R å‡½æ•°â€”â€”R éœ€æ±‚æ— ç”¨é‡‘å­—å¡”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€TME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šWhat motivates human behaviour can be captured in the Maslowâ€™s hierarchy of needs (source: Wiki). Maslow and psychologists have articulated these needs in a form of a Pyramid, and ever since the concept had been widely adopted (also criticised), andâ€¦Read more â€º Continue reading: Little useless-useful R functions â€“ Useless Pyramid of R needs<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/little-useless-useful-r-functions-useless-pyramid-of-r-needs/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>Python package development for R developers (episode 2 !)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šIn a previous article, I shared my experience as an R developer diving into Python package development! I had noted several aspects that felt less smooth than in R, or even completely missing! Thanks to feedback from the community, Iâ€™ve been abl... Continue reading: Python package development for R developers (episode 2 !)<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/python-package-development-for-r-developers-episode-2/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>Evaluating a New Job Market Data Feed</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šIâ€™ve recently been given early access to a service that provides data on job listings published by a wide range of companies. The dataset offers a near real-time view of hiring activity, broken down at the company level. This is a potentially valuable signal for tracking labour market trends, ... Continue reading: Evaluating a New Job Market Data Feed<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/evaluating-a-new-job-market-data-feed/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>365 Data Science æä¾›å…è´¹äººå·¥æ™ºèƒ½å’Œæ•°æ®è¯¾ç¨‹â€”â€”æ— é™æ¬¡è®¿é—®è‡³ 11 æœˆ 21 æ—¥</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼š365 Data Science opens its doors this November 100% for free! From November 6 to November 21, 2025 (8 a.m. UTC), enjoy unlimited access to the entire platform, including a wide range of R programming courses and projects. This offer features expert-led courses, practical projects, and interactive exercises covering diverse topics in AI and data â€¦ ... Continue reading: Free AI and Data Courses with 365 Data Scienceâ€”Unlimited Access until Nov. 21<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/free-ai-and-data-courses-with-365-data-science-unlimited-access-until-nov-21/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>ä¼˜é›…çš„ç½‘ç»œå¥—é¤</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šR package<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šHow to join this free online event with Salix Dubois, Tan Ho and Matthias GreniÃ©. Join us for our next Community Call, â€œGraceful Internet Packages,â€ featuring Matthias, Tan, and Salix. In this session, weâ€™ll explore how to design and maintain R packag... Continue reading: Graceful Internet Packages<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/graceful-internet-packages/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>Maestro 0.7.0 å¼•å…¥äº†æ¡ä»¶ç®¡é“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscDNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šThe 0.7.0 release of maestro is out, and with it is the ability to conditionally run pipelines. In a nutshell, this is especially useful when you have DAG pipelines and you want to branch or only execute parts of a DAG when the output meets a pa... Continue reading: maestro 0.7.0 introduces conditional pipelines<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/maestro-0-7-0-introduces-conditional-pipelines/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (61æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>SPT Labtech å’Œ Alithea Genomics åˆä½œï¼Œå®ç°è¶…çµæ•å•ç»†èƒè½¬å½•ç»„å­¦å·¥ä½œæµç¨‹çš„è‡ªåŠ¨åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€TMEã€TCGAã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomicsã€proteomicsã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing and transcriptomics, today announced a collaboration to provide an automated solution for single-cell transcriptomics. The collaboration integrates Alithea Genomicsâ€™ ultra-sensitive single-cell RNA-seq technology, MERCURIUSâ„¢ FLASH-seq, ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/spt-labtech-and-alithea-genomics-collaborate-to-automate-ultra-sensitive-single-cell-transcriptomic-workflows/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>RNAæµ‹åºæ­ç¤ºäº†å¯ç”¨äºæ”¹è¿›è‚ºå¤–ç»“æ ¸ç—…è¯Šæ–­çš„å…ç–«ç”Ÿç‰©æ ‡å¿—ç‰©</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€immunityã€TMEã€cardiacã€gliomaã€sequencingã€RNAseqã€scRNAã€scDNAã€scATACã€Visiumã€genomeã€genomicsã€Seuratã€Scanpy<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing identifies immune biomarkers for extrapulmonary tuberculosis, revealing new molecular signatures in blood that may improve diagnosis and enable personalized treatment...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rna-sequencing-reveals-immune-biomarkers-for-improved-diagnosis-of-extrapulmonary-tuberculosis/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>ç ”ç©¶äººå‘˜æ¨å‡ºäº†ä¸€ç§æ–°å·¥å…·ï¼Œå¯ä»çº³ç±³å­”ä¿¡å·ä¸­æ›´å‡†ç¡®åœ°æ£€æµ‹RNAä¿®é¥°ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€cardiacã€TCGAã€scRNAã€scDNAã€scATACã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers from the University of Eastern Finland and Aalto University have developed a computational framework called SegPore, which enhances the accuracy of RNA modification detection from direct RNA nanopore sequencing data. RNA modifications are essential epigenetic regulators of gene expression and are involved in diverse biological processes, including cell differentiation, stress response and disease ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/researchers-introduce-a-new-tool-for-more-accurate-rna-modification-detection-from-nanopore-signals/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>åœ°çƒæ­£åœ¨ç¼“æ…¢åœ°ä»ä¸‹æ–¹å‰¥ç¦»å…¶å¤§é™†æ¿å—ï¼Œä»è€Œå¼•å‘æµ·æ´‹ç«å±±æ´»åŠ¨ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€TCGAã€scRNAã€genomeã€genomicsã€epigenomeã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers discovered that continents donâ€™t just split at the surfaceâ€”they also peel from below, feeding volcanic activity in the oceans. Simulations reveal that slow mantle waves strip continental roots and push them deep into the oceanic mantle. Data from the Indian Ocean confirms this hidden recycling process, which can last tens of millions of years.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251112011806.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>Physicists prove the Universe isnâ€™t a simulation after all</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€TMEã€scRNAã€spatialã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šNew research from UBC Okanagan mathematically demonstrates that the universe cannot be simulated. Using GÃ¶delâ€™s incompleteness theorem, scientists found that reality requires â€œnon-algorithmic understanding,â€ something no computation can replicate. This discovery challenges the simulation hypothesis and reveals that the universeâ€™s foundations exist beyond any algorithmic system.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251110021052.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>New research finds no clear link between acetaminophen (Tylenol) and autism</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€scRNAã€scDNAã€scATACã€Scanpyã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA sweeping review of existing studies finds no solid evidence that using acetaminophen (Tylenol) during pregnancy increases the risk of autism or ADHD in children. Researchers found that previous reviews often relied on weak or biased data, and most did not properly account for genetic or environmental factors shared by families. When these factors were considered, any apparent link between acetaminophen use and neurodevelopmental disorders largely disappeared.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251110021050.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>Stanford discovers an extraordinary crystal that could transform quantum tech</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€cardiacã€scRNAã€scDNAã€scATACã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šStanford scientists found that strontium titanate improves its performance when frozen to near absolute zero, showing extraordinary optical and mechanical behavior. Its nonlinear and piezoelectric properties make it ideal for cryogenic quantum technologies. Once overlooked, this cheap, accessible material now promises to advance lasers, computing, and space exploration alike.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251108083912.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>Scientists find brain cells that could stop Alzheimerâ€™s</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€Alzheimerã€scRNAã€scDNAã€scATAC<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have identified special immune cells in the brain that help slow Alzheimerâ€™s. These microglia work to reduce inflammation and block the spread of harmful proteins. They appear to protect memory and brain health, offering a promising new direction for therapy.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251108083902.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>Tiny laser could transform medicine and quantum science</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€TMEã€cardiacã€scRNAã€scDNAã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA team at the University of Stuttgart has engineered a compact short-pulse laser that achieves up to 80% efficiencyâ€”far surpassing current models. Their new multipass design reuses light within a small crystal, combining power and precision in a palm-sized system. It opens the door to portable, cost-effective lasers for medicine, analytics, and quantum science.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251108083854.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>åˆ©ç”¨å°RNAæµ‹åºæŠ€æœ¯å¯¹è·—åº“èšŠè¿›è¡Œç—…æ¯’ç»„åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€gliomaã€RNA-seqã€RNAseqã€Visium<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing reveals diverse insect-specific viruses in Culex tarsalis mosquitoes, improving understanding of viral interactions and aiding mosquito-borne disease surveillance...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/virome-profiling-of-culex-tarsalis-through-small-rna-seq/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 51 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-åšå®¢æ›´æ–°">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>TME</td>
<td>95</td>
</tr>
<tr>
<td>scRNA</td>
<td>72</td>
</tr>
<tr>
<td>scDNA</td>
<td>60</td>
</tr>
<tr>
<td>Seurat</td>
<td>54</td>
</tr>
<tr>
<td>scATAC</td>
<td>53</td>
</tr>
<tr>
<td>cancer</td>
<td>49</td>
</tr>
<tr>
<td>genome</td>
<td>46</td>
</tr>
<tr>
<td>TCGA</td>
<td>45</td>
</tr>
<tr>
<td>spatial</td>
<td>36</td>
</tr>
<tr>
<td>glioma</td>
<td>34</td>
</tr>
<tr>
<td>tumor</td>
<td>32</td>
</tr>
<tr>
<td>histone</td>
<td>32</td>
</tr>
<tr>
<td>cardiac</td>
<td>29</td>
</tr>
<tr>
<td>genomics</td>
<td>28</td>
</tr>
<tr>
<td>Scanpy</td>
<td>26</td>
</tr>
<tr>
<td>proteome</td>
<td>25</td>
</tr>
<tr>
<td>immune</td>
<td>24</td>
</tr>
<tr>
<td>epigenome</td>
<td>23</td>
</tr>
<tr>
<td>Hi-C</td>
<td>20</td>
</tr>
<tr>
<td>epigenetic</td>
<td>20</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (44æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MDk1NTY5MA==&amp;mid=2247540945&amp;idx=1&amp;sn=7f976c3b646e06f483d66c07e08c10e3" target="_blank" rel="noopener noreferrer">ã€ç½‘ç»œç ”è®¨ä¼šã€‘åˆ©ç”¨å•ç»†èƒä¸ç©ºé—´å¤šç»„å­¦æ¢ç´¢å¾®ç”Ÿç‰©ç»„ä¸å…ç–«äº’ä½œæœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503943&amp;idx=6&amp;sn=172af37f98d4551cd59ffaf0c05ffb4d" target="_blank" rel="noopener noreferrer">æœ€æ–°7.9åˆ†ç”Ÿä¿¡ï¼Œèšç„¦æ°¨åŸºé…¸ä»£è°¢çƒ­ç‚¹ï¼Œåˆ†æä¸å¤šï¼Œå®éªŒä¹Ÿåªæœ‰PCRã€‚é€‚åˆçŸ­å¹³å¿«å‘æ–‡ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247505925&amp;idx=1&amp;sn=9ae3348ff1e2b73ac3181182ba4fff29" target="_blank" rel="noopener noreferrer">CellÂ |Â æ¨Šå˜‰/å­£å½¤/å‘¨ä¿­/å­™äº‘å¸†/å¼ é™ˆå¹³åˆä½œæ­ç¤ºè‚¿ç˜¤åˆ©ç”¨ç¥ç»ä»‹å¯¼çš„è·¨å™¨å®˜é€šè®¯å®ç°å…ç–«é€ƒé€¸</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506562&amp;idx=3&amp;sn=4f83ef7ea3583426dee4d03a3f9e93b6" target="_blank" rel="noopener noreferrer">Natureç»¼è¿°ï¼é“æ­»äº¡ä¸è‚¿ç˜¤å…ç–«æ²»ç–—</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506562&amp;idx=2&amp;sn=0a30eefe918402989e6c3459684d00e2" target="_blank" rel="noopener noreferrer">Science | äººç±»æ³›ç–¾ç—…è¡€æ¶²è›‹ç™½è´¨ç»„å›¾è°±ï¼šå¾ªç¯è›‹ç™½è´¨ç»„çš„å…¨æ™¯è§£æä¸ç²¾å‡†åŒ»å­¦åº”ç”¨</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568174&amp;idx=1&amp;sn=918f0474afe65550b9a52e83a8a2a2bb" target="_blank" rel="noopener noreferrer">ã€Šè‡ªç„¶ã€‹ï¼šæœ‰æœ›å®Œå…¨æ¸…é™¤è‚¿ç˜¤ï¼è¿™ç§é¥®é£Ÿæ¨¡å¼ä¸è¯ç‰©è”ç”¨ï¼Œè®©è‡´å‘½ç™Œç—‡â€œæ”¹é‚ªå½’æ­£â€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568238&amp;idx=1&amp;sn=220ceb52eff7305b26b9646b145184ae" target="_blank" rel="noopener noreferrer">ã€Šè‡ªç„¶ã€‹é‡ç£…ï¼šä¸‰å¹´ç”Ÿå­˜ç‡æ¥è¿‘ç¿»å€ï¼æ²»ç–—ç™Œç—‡çš„ç–«è‹—å·²ç»å‡ºç°äº†ï¼Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657847&amp;idx=2&amp;sn=547be09ce30923ea53fb5555005918c4" target="_blank" rel="noopener noreferrer">Cell: è‚ -è„‘è½´ä¿¡å·é€šè·¯é™åˆ¶åˆ†è§£ä»£è°¢æ¢å¤æœŸçš„è†³é£Ÿè›‹ç™½æ‘„å…¥ | Cell Pressè®ºæ–‡é€Ÿé€’</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649875&amp;idx=3&amp;sn=3883964cee1ba69740a8ddf851223a03" target="_blank" rel="noopener noreferrer">Cell Stem Cellï¼šæ›¾å®‰ç»„åˆä½œæ­ç¤ºå¿ƒè„å†ç”Ÿå…³é”®ç»†èƒ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMjE4NDc2Mw==&amp;mid=2247502978&amp;idx=1&amp;sn=fd491753798bd5da131fb56783372df3" target="_blank" rel="noopener noreferrer">é€šè·¯å¯Œé›†ç»“æœå±•ç¤ºä¸å†åƒç¯‡ä¸€å¾‹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkwODUyOTYzMw==&amp;mid=2247488609&amp;idx=1&amp;sn=c2954eb09c3865a3f16d87047111a3ae" target="_blank" rel="noopener noreferrer">ç”Ÿä¿¡å®ç”¨æŠ€èƒ½ç›˜ç‚¹ | md5sum</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484032&amp;idx=1&amp;sn=9b8ad353c3c456831fddf5206f967956" target="_blank" rel="noopener noreferrer">è¯¦è§£ï¼š2å‹ç³–å°¿ç—…çš„ä»£è°¢æœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498467&amp;idx=1&amp;sn=c7b200800464e088ecd561197473ee57" target="_blank" rel="noopener noreferrer">å…¨åŸºå› ç»„ç»“æ„å˜å¼‚æ£€æµ‹æœ‰å›°éš¾ï¼ŸSyRIå¸®ä½ é€šé€šæå®šï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503943&amp;idx=2&amp;sn=86fa16db8c4425cd73411a193ab9870e" target="_blank" rel="noopener noreferrer">æ°¨åŸºé…¸ä»£è°¢æ˜¯çœŸçš„ç«ï¼Œå¹²æ¹¿ç»“åˆè½»æ¾å‘7.5åˆ†2åŒºæ–‡ç« ã€‚ç°åœ¨ä¸‹æ‰‹è¿˜ä¸æ™šï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546875&amp;idx=1&amp;sn=692f800c63d56b43e257250562ec0866" target="_blank" rel="noopener noreferrer">pythonå•ç»†èƒå­¦ä¹ ï¼ˆäºŒï¼‰ï¼šä½¿ç”¨pythonæ‰¹é‡åŠ é€Ÿè¯»å–countçŸ©é˜µ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU0ODQyNjQxOA==&amp;mid=2247555001&amp;idx=1&amp;sn=c4017fea43ace2eaa584cebabeb9c31a" target="_blank" rel="noopener noreferrer">Nat Methods | åŠ å·å¤§å­¦é¦–æ¬¡å®ç°é¢…è„‘ç³»ç»Ÿå¤§å°ºåº¦äºšå¾®ç±³åˆ†è¾¨ç‡åŸä½ä¸‰ç»´æˆåƒ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247505754&amp;idx=2&amp;sn=ca3489ef70749e73032271d660a87030" target="_blank" rel="noopener noreferrer">STTTï½œæå°/åˆ˜èŠåå›¢é˜Ÿç»˜åˆ¶é£Ÿç®¡é³ç™Œå…ç–«ç”Ÿæ€ç³»ç»Ÿå…¨æ™¯å›¾è°±ï¼Œæ­ç¤ºç”Ÿç‰©æ ‡å¿—ç‰©å’Œæ²»ç–—æ–°é¶ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247505867&amp;idx=1&amp;sn=054733643f3bd32006525c3bf8d66023" target="_blank" rel="noopener noreferrer">Nat Commun | æä¹å›­/Daniel Figeyså›¢é˜Ÿæ­ç¤ºè¯ç‰©åœ¨è›‹ç™½è´¨å±‚é¢é‡å¡‘è‚ é“å¾®ç”Ÿæ€åŠŸèƒ½ç¨³æ€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506054&amp;idx=2&amp;sn=6a5ef65a21c32cc59dcb12195d0f5416" target="_blank" rel="noopener noreferrer">Cell | éƒ­å¤©å—å›¢é˜Ÿç»˜åˆ¶è›‹ç™½è´¨é™åˆ¶é‡ç¼–ç¨‹å°é¼ è¡°è€çš„å¤šå™¨å®˜è›‹ç™½ç»„æ™¯è§‚</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506355&amp;idx=1&amp;sn=265b7087371d2b3a3ded6d9104889272" target="_blank" rel="noopener noreferrer">Cell Discoveryï½œÏ€-HuB æ•°æ®å·¥å‚å¼€å¯æ— äººåŒ–è›‹ç™½è´¨ç»„å­¦æ•°æ®ç”Ÿäº§æ–°çºªå…ƒ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506401&amp;idx=1&amp;sn=1635f84a177205fd1bec1035b41c3b42" target="_blank" rel="noopener noreferrer">æ–‡çŒ®é€Ÿé€’âˆ£è›‹ç™½è´¨ç»„å­¦ç ”ç©¶åŠ¨æ€ï¼ˆåæœˆï¼‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506556&amp;idx=3&amp;sn=76473d73c09b7057623332aea32ece5f" target="_blank" rel="noopener noreferrer">Nature Medicineï¼šå¼ åº·/é™ˆé¦™ç¾åˆä½œå¼€å‘AIç”Ÿå‘½æ—¶é’Ÿï¼Œå‡†ç¡®é¢„æµ‹ä»å©´å„¿åˆ°è€å¹´çš„ç”Ÿç‰©å­¦å¹´é¾„åŠç–¾ç—…é£é™©</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506556&amp;idx=2&amp;sn=9f7e4dff0f231ea6d73cedd64a733838" target="_blank" rel="noopener noreferrer">è¡Œè·¯éš¾ï¼è¡Œè·¯éš¾ï¼å¤šæ­§è·¯ï¼Œä»Šå®‰åœ¨ï¼Ÿâ€”â€”èƒšèƒå‘è‚²å™¨å®˜å‘ç”Ÿå•ç»†èƒç»„å­¦æ•°æ®åº“OrganogenesisDBçš„ç ”ç©¶å†ç¨‹å›é¡¾</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506556&amp;idx=1&amp;sn=1c87aa5de1eb14d8f40d2734f193d90e" target="_blank" rel="noopener noreferrer">è›‹ç™½è´¨ç»„å­¦ä¸´åºŠè½¬åŒ–åŒçªç ´ï¼šä¸¤å¤§è¯•å‰‚ç›’è·æ‰¹å¼•é¢†ç²¾å‡†è¯Šç–—æ–°æ—¶ä»£</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506573&amp;idx=2&amp;sn=ba75cdac2d05f2816bad4fe1a988d872" target="_blank" rel="noopener noreferrer">Nature | å¤šç»„å­¦è§£æè¡°è€çš„å…ç–«</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506623&amp;idx=3&amp;sn=ebea764be2e28cb2e3b6a999bbb5114f" target="_blank" rel="noopener noreferrer">Natureï¼šå…¨çƒç™Œç—‡ç»†èƒç–—æ³•ä¸´åºŠè¶‹åŠ¿</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247506980&amp;idx=1&amp;sn=1df98fee111d6706314a824ab90c546b" target="_blank" rel="noopener noreferrer">æ›²é™/åˆ˜å…‰æ…§/å¼ ç»´ç»®æ­ç¤ºæ ¸çº¤å±‚è›‹ç™½â€œå»ºç­‘å¸ˆâ€é€šè¿‡â€œå†…å¤–å…¼ä¿®â€æ„ç­‘ä¸‰ç»´åŸºå› ç»„ç»“æ„</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507020&amp;idx=2&amp;sn=12108ad369ad1f76d099624a94062611" target="_blank" rel="noopener noreferrer">Nature | GWASä¸è´Ÿè·æµ‹è¯•ï¼šæ®Šé€”ä¸ºä½•ä¸åŒå½’ï¼Ÿè§£å¯†åŸºå› å…³è”ç ”ç©¶ä¸­çš„æ’åºä¹‹è°œ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507070&amp;idx=3&amp;sn=909d2ce3e9bdb62e333c3c57a73b2c60" target="_blank" rel="noopener noreferrer">èƒŒé èƒŒNature | è§¦å‘â€œå¤è€â€çš„æ­»äº¡ï¼ŒæŠ‘åˆ¶æ¶æ€§çš„è‚¿ç˜¤</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkyNDI1MzE0NA==&amp;mid=2247490127&amp;idx=1&amp;sn=a4a338b0a2381d97d33083acde300cb4" target="_blank" rel="noopener noreferrer">å•ç»†èƒåˆ†è¾¨ç‡çš„è¡¨è¾¾å’Œå˜å¼‚è”åˆåˆ†æ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568179&amp;idx=2&amp;sn=4080da1a140929e7a8790f5672222af5" target="_blank" rel="noopener noreferrer">NEJMï¼šæ™šæœŸæˆ–è½¬ç§»æ€§è‚ºç™Œæ‚£è€…ç¼“è§£ç‡é«˜è¾¾71%ï¼é¶å‘æ–°è¯æ˜¾ç¤ºæŒä¹…æŠ—è‚¿ç˜¤æ´»æ€§</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568179&amp;idx=1&amp;sn=4a8d95afd8e59068c65f4649de00e8f7" target="_blank" rel="noopener noreferrer">ã€Šè‡ªç„¶ã€‹å­åˆŠï¼šä¸­å›½ç§‘å­¦å®¶æ­å¼€è‚ç™Œè½¬ç§»æ–°æœºåˆ¶ï¼è¿™äº›ç»†èƒå˜èº«è‚¿ç˜¤çš„â€œèƒ½é‡å·¥å‚â€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568303&amp;idx=1&amp;sn=af81a0e257c2ea1268314f3f262625c9" target="_blank" rel="noopener noreferrer">æ–°æ™‹è¯ºå¥–å¾—ä¸»æœ€æ–°è®ºæ–‡ï¼ä¸ºç‰¹æ®Šå…ç–«ç–¾ç—…å¸¦æ¥æ²»ç–—å¸Œæœ›</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568418&amp;idx=1&amp;sn=c0d281a302fb7312fef85659c83e05a3" target="_blank" rel="noopener noreferrer">èƒ½æ´»ä¸¤ç™¾å²ï¼Œä¸”å‡ ä¹ä¸å¾—ç™Œç—‡ï¼ã€Šè‡ªç„¶ã€‹ï¼šå®ƒä»¬å¥åº·é•¿å¯¿çš„å…³é”®æœºåˆ¶æ‰¾åˆ°äº†</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568513&amp;idx=2&amp;sn=7641c217c6ac8bbe11fa4bfcf9479b4e" target="_blank" rel="noopener noreferrer">â€œç™Œç—‡ä¹‹ç‹â€ç–¾ç—…æ§åˆ¶ç‡è¾¾100%ï¼ä¸Šç™¾æ¬¾æ–°è¯åœ¨ç ”ï¼Œä¸ºæ‚£è€…å¸¦æ¥æ–°æ›™å…‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568569&amp;idx=1&amp;sn=e49c800cd443673e364fbfb601f2315d" target="_blank" rel="noopener noreferrer">æ— è¿›å±•ç”Ÿå­˜æœŸç¿»å€ï¼é¢å¯¹æœ€è‡´å‘½çš„ç™Œç—‡ä¹‹ä¸€ï¼Œè¿™äº›ç–—æ³•æ­£åœ¨ç‚¹äº®æ²»ç–—ä¹‹å…‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568620&amp;idx=2&amp;sn=6bc01ce0780af268efb127730fb64603" target="_blank" rel="noopener noreferrer">è¿‘80%è‚¿ç˜¤è¢«æŠ‘åˆ¶ï¼é¶å‘ç™Œç»†èƒâ€œå¸®å‡¶â€ï¼Œæ–°ç–—æ³•æœ‰æœ›è®©å†·è‚¿ç˜¤è¿æ¥æ²»ç–—è½¬æœº</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568705&amp;idx=1&amp;sn=a9e3552e014e0e45aadc77d1890600d3" target="_blank" rel="noopener noreferrer">ç”Ÿå­˜ç‡å¯è¾¾90%ä»¥ä¸Šï¼è·¨è¶ŠåŠä¸ªä¸–çºªçš„æŠ—ç™Œæ¥åŠ›ï¼Œæ”¹å†™å…¨çƒå¥³æ€§æœ€å¸¸è§ç™Œç—‡çš„æ²»ç–—æ ¼å±€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568770&amp;idx=1&amp;sn=eeb6a54ff35088033b32d7c076ded9b4" target="_blank" rel="noopener noreferrer">ã€Šè‡ªç„¶ã€‹ï¼šè‚¿ç˜¤ç¼©å°è¶…80%ï¼é˜»æ–­è¿™ä¸ªè›‹ç™½ï¼Œè®©ç™Œç»†èƒâ€œè‡ªæˆ‘æ¯ç­â€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509583&amp;idx=2&amp;sn=992822d3a6cae39dfabf804970dd5a0e" target="_blank" rel="noopener noreferrer">æ´è§Â·æ¢æœº|å¤–æ³Œä½“ä¸å¤–å‘¨å…ç–«ï¼Œå¼•é¢†å›½è‡ªç„¶ç”³æŠ¥æ–°èµ›é“</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509583&amp;idx=1&amp;sn=18dcd522fcff473ac99ff03c129b94c1" target="_blank" rel="noopener noreferrer">èƒ¡å¿—æ–Œæ•™æˆé¢†è¡”ï¼æ­ç¤ºæ¯ä½“èƒ†å›ºé†‡æ°´å¹³è°ƒæ§èƒå„¿å¿ƒè„å‘è‚²æœºåˆ¶ï¼Œé¥®é£Ÿå¹²é¢„æˆ–æˆé¢„é˜²å…ˆå¤©æ€§å¿ƒè„ç—…æ–°ç­–ç•¥</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649875&amp;idx=1&amp;sn=b6fc666d4045a581232a52a663a4bb48" target="_blank" rel="noopener noreferrer">è¯ºå¥–é¢†èˆªï¼ä¸­å±±å¤§å­¦ã€å±±ä¸œå¤§å­¦ã€æ¸…åå¤§å­¦ã€å››å·å¤§å­¦ç­‰å›¢é˜Ÿçªç ´æ€§è¿›å±•ï¼Œè§£æå›½è‡ªç„¶å…ç–«çƒ­ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498876&amp;idx=1&amp;sn=97704b03e2e4047e889001b38ca2a155" target="_blank" rel="noopener noreferrer">è„šæœ¬æ›´æ–°--é«˜ç²¾åº¦ç©ºè½¬ï¼ˆXeniumã€CoxMxã€HDï¼‰ç©ºé—´é‚»åŸŸä¸å·®å¼‚è¡¨è¾¾åˆ†æ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5OTgxNzU3NQ==&amp;mid=2247558411&amp;idx=1&amp;sn=148613e1869ea989a66b8365e5b42242" target="_blank" rel="noopener noreferrer">é‡ç£…è¿”åœºï¼åŸä½è‚¿ç˜¤æ¨¡å‹æ„å»ºå®è®­ç­å³å°†å†æ¬¡å¯åŠ¨ï¼</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (35æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281686" target="_blank" rel="noopener noreferrer">GSE281686 C57BL6/j å’Œ 129S1/SvImJ å°é¼ ç™½è‰²è„‚è‚ªç»„ç»‡ä¸­çš„è½¬å½•å› å­å ä½å—é—ä¼ å˜å¼‚çš„å½±å“ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255608" target="_blank" rel="noopener noreferrer">GSE255608 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [æ‰°åŠ¨æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281685" target="_blank" rel="noopener noreferrer">GSE281685 C57BL6/j å’Œ 129S1/SvImJ å°é¼ ç™½è‰²è„‚è‚ªç»„ç»‡ä¸­çš„è½¬å½•å› å­å ä½å—é—ä¼ å˜å¼‚çš„å½±å“ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303818" target="_blank" rel="noopener noreferrer">GSE303818 è§£è€¦è¯ç‰©å’Œå¾®ç”Ÿç‰©ç¾¤å¯¹åŒ–ç–—å¼•èµ·çš„è‚ é“æ¯’æ€§çš„è´¡çŒ® [16S rRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303815" target="_blank" rel="noopener noreferrer">GSE303815 è§£è€¦è¯ç‰©å’Œå¾®ç”Ÿç‰©ç¾¤å¯¹åŒ–ç–—å¼•èµ·çš„è‚ é“æ¯’æ€§çš„è´¡çŒ® [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297256" target="_blank" rel="noopener noreferrer">GSE297256 å•ç»†èƒæ˜ å°„æ­ç¤ºéª¨è†œç¥–ç»†èƒå’Œå…ç–«å¾®ç¯å¢ƒçš„å¹´é¾„ç›¸å…³æ”¹å˜ï¼Œè¿™äº›æ”¹å˜ä¼šæŸå®³éª¨å†ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293813" target="_blank" rel="noopener noreferrer">GSE293813 PITX2å‰‚é‡ä¾èµ–æ€§èµ·æç»†èƒçŠ¶æ€å˜åŒ–æ˜¯çª¦æˆ¿ç»“åŠŸèƒ½éšœç¢å’Œå¿ƒæˆ¿å¿ƒå¾‹å¤±å¸¸æ˜“æ„Ÿæ€§çš„åŸºç¡€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291752" target="_blank" rel="noopener noreferrer">GSE291752 PITX2å‰‚é‡ä¾èµ–æ€§èµ·æç»†èƒçŠ¶æ€æ”¹å˜æ˜¯çª¦æˆ¿ç»“åŠŸèƒ½éšœç¢å’Œå¿ƒæˆ¿å¿ƒå¾‹å¤±å¸¸æ˜“æ„Ÿæ€§çš„åŸºç¡€ III</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291749" target="_blank" rel="noopener noreferrer">GSE291749 PITX2å‰‚é‡ä¾èµ–æ€§èµ·æç»†èƒçŠ¶æ€æ”¹å˜æ˜¯çª¦æˆ¿ç»“åŠŸèƒ½éšœç¢å’Œå¿ƒæˆ¿å¿ƒå¾‹å¤±å¸¸æ˜“æ„Ÿæ€§çš„åŸºç¡€ II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291746" target="_blank" rel="noopener noreferrer">GSE291746 PITX2å‰‚é‡ä¾èµ–æ€§èµ·æç»†èƒçŠ¶æ€æ”¹å˜æ˜¯çª¦æˆ¿ç»“åŠŸèƒ½éšœç¢å’Œå¿ƒæˆ¿å¿ƒå¾‹å¤±å¸¸æ˜“æ„Ÿæ€§çš„åŸºç¡€ I</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280039" target="_blank" rel="noopener noreferrer">GSE280039 METTL3 dependent m6A RNA methylation is required for self-renewal and cell identity maintenance of human trophoblast stem cells</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278737" target="_blank" rel="noopener noreferrer">GSE278737 è‚ºåŠ¨è„‰é«˜å‹ä¸­è‚ºé©»ç•™å·¨å™¬ç»†èƒå’Œå‹Ÿé›†å·¨å™¬ç»†èƒçš„åŸºå› è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308249" target="_blank" rel="noopener noreferrer">GSE308249 å‰ªæ¥å› å­ PTBP1 ä¸ RUNX1 ç›¸äº’ä½œç”¨ï¼Œæ˜¯ç™½è¡€ç—…ç»†èƒå­˜æ´»æ‰€å¿…éœ€çš„ [é•¿ç¯‡é˜…è¯»]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217909" target="_blank" rel="noopener noreferrer">GSE217909 åœ¨è‘¡è„ç³–æˆ–å¾®æ™¶çº¤ç»´ç´ åŸ¹å…»æ¡ä»¶ä¸‹ï¼Œè‰é…¸é’éœ‰ä¸­ PoxCxrE åŸºå› ç¼ºå¤±å¯¼è‡´çš„å…¨åŸºå› ç»„åŸºå› è¡¨è¾¾æ”¹å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299947" target="_blank" rel="noopener noreferrer">GSE299947 Plagl1 å’Œ Lrrc58 é€šè¿‡è§¦å‘ miR-322 å’Œ miR-503 çš„é¶å‘ microRNA é™è§£æ¥æ§åˆ¶å“ºä¹³åŠ¨ç‰©çš„ä½“å‹ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308248" target="_blank" rel="noopener noreferrer">GSE308248 å‰ªæ¥å› å­ PTBP1 ä¸ RUNX1 ç›¸äº’ä½œç”¨ï¼Œæ˜¯ç™½è¡€ç—…ç»†èƒå­˜æ´»æ‰€å¿…éœ€çš„ [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281688" target="_blank" rel="noopener noreferrer">GSE281688 è½¬å½•å› å­å ä½å—C57BL6/jå’Œ129S1/SvImJå°é¼ ç™½è‰²è„‚è‚ªç»„ç»‡é—ä¼ å˜å¼‚çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300224" target="_blank" rel="noopener noreferrer">GSE300224 å¹²æ€§å› å­ Mex3a è°ƒèŠ‚ç¿»è¯‘å’Œè›‹ç™½è´¨è¿è¾“ï¼Œä»¥ç¡®ä¿å—…è§‰æ„Ÿè§‰ç¥ç»å…ƒçš„ç¨³å¥åˆ†åŒ– [HyperTRIBE]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271853" target="_blank" rel="noopener noreferrer">GSE271853 è‡ªé—­ç—‡è°±ç³»éšœç¢äººç±»å¹²ç»†èƒæ¨¡å‹çš„å‘è‚²è¶‹åŒä¸åˆ†åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299946" target="_blank" rel="noopener noreferrer">GSE299946 Plagl1 and Lrrc58 control mammalian body size by triggering target-directed microRNA degradation of miR-322 and miR-503 [AGO-CLASH]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308010" target="_blank" rel="noopener noreferrer">GSE308010 åŸºäºäººç±»è¯±å¯¼å¤šèƒ½å¹²ç»†èƒçš„ç¥ç»çƒä½“å¹³å°ï¼Œç”¨äºåˆ©ç”¨é«˜å†…æ¶µæˆåƒæŠ€æœ¯æ¨¡æ‹Ÿèƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297919" target="_blank" rel="noopener noreferrer">GSE297919 NSUN7 æ˜¯ä¸€ç§ RNA:m5C å‚¬åŒ–å¤±æ´»è›‹ç™½ï¼Œå¯è°ƒæ§ç²¾å­é­æ¯›ç»„è£… [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228081" target="_blank" rel="noopener noreferrer">GSE228081 å°åˆ†å­L-2-ç¾ŸåŸºæˆŠäºŒé…¸å¯¹è‚¾ç™Œä¸­mRNA m6Açš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304501" target="_blank" rel="noopener noreferrer">GSE304501 A circadian checkpoint relocates neutrophils to minimize injury</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297485" target="_blank" rel="noopener noreferrer">GSE297485 NSUN7 æ˜¯ä¸€ç§ RNA:m5C å‚¬åŒ–å¤±æ´»è›‹ç™½ï¼Œå¯è°ƒèŠ‚ç²¾å­é­æ¯›çš„ç»„è£…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277032" target="_blank" rel="noopener noreferrer">GSE277032 äººç±»èƒå„¿ä¸­è„‘å‘è‚²çš„ä½“å†…å’Œä½“å¤–æ—¶ç©ºå›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282618" target="_blank" rel="noopener noreferrer">GSE282618 Multiomics Investigation of the Hypertensive Human Heart</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295023" target="_blank" rel="noopener noreferrer">GSE295023 MSS2ä»‹å¯¼çš„ROSå’Œé’™å¯¹ç™½è‰²å¿µç èŒçš„ä¾µè¢­è¡Œä¸ºå’Œæ¯’åŠ›è‡³å…³é‡è¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281663" target="_blank" rel="noopener noreferrer">GSE281663 IL-16 ç¼ºä¹å¯¹å°é¼ é«˜è„‚é¥®é£Ÿ 24 å‘¨ååŸºå› è¡¨è¾¾çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309408" target="_blank" rel="noopener noreferrer">GSE309408 æ¯”è¾ƒçœ¼è½¬å½•ç»„å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307234" target="_blank" rel="noopener noreferrer">GSE307234 Transcriptomic Regulation of TCF12 Isoform Switching</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292698" target="_blank" rel="noopener noreferrer">GSE292698 Silencing of BCL11A by Disrupting Enhancer-Dependent Chromatin Insulation</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218452" target="_blank" rel="noopener noreferrer">GSE218452 åˆ©ç”¨RNA-Seqæ¢ç´¢INHBAåœ¨æ¹–ç¾Šé¢—ç²’ç»†èƒä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280833" target="_blank" rel="noopener noreferrer">GSE280833 ç»„è›‹ç™½H4å¯¹ç»„è›‹ç™½åŸºå› è½¬å½•çš„ç»†èƒå‘¨æœŸä¾èµ–æ€§æŠ‘åˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291173" target="_blank" rel="noopener noreferrer">GSE291173 Polycomb-dependent breakdown of the intestinal barrier in aging Drosophila</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-åšå®¢æ›´æ–°"></a>ğŸ§ª åšå®¢æ›´æ–° å…¶ä»–å†…å®¹ (51æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013242.htm" target="_blank" rel="noopener noreferrer">A simple DNA test could reveal the right antidepressant for you</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108083900.htm" target="_blank" rel="noopener noreferrer">Common pesticides may cause testicular damage and lower sperm counts</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010306.htm" target="_blank" rel="noopener noreferrer">After 250 years, an 18th-century mechanical volcano erupts to life</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010252.htm" target="_blank" rel="noopener noreferrer">CERN creates cosmic â€œfireballsâ€ that could reveal the Universeâ€™s hidden magnetism</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251112011803.htm" target="_blank" rel="noopener noreferrer">ç§‘å­¦å®¶éœ‡æƒŠï¼šå¤§é»„èœ‚å­¦ä¼šé˜…è¯»ç®€å•çš„â€œæ‘©å°”æ–¯ç”µç â€</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111010008.htm" target="_blank" rel="noopener noreferrer">åœ°çƒä¸Šæœ€ç¨€æœ‰çš„å…ƒç´ æˆ–å°†å½»åº•æ”¹å˜ç™Œç—‡æ²»ç–—ã€‚</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111005949.htm" target="_blank" rel="noopener noreferrer">Scientists turn body fat into bone to heal spinal fractures</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111005947.htm" target="_blank" rel="noopener noreferrer">Scientists uncover a hidden universal law limiting lifeâ€™s growth</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021114.htm" target="_blank" rel="noopener noreferrer">Scientists find brain chemical tied to trauma and depression</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021058.htm" target="_blank" rel="noopener noreferrer">Goodbye cavities? This new toothpaste made from hair can heal enamel</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021048.htm" target="_blank" rel="noopener noreferrer">Archaeologists may have finally solved Peruâ€™s strange â€œBand of Holesâ€ mystery</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021041.htm" target="_blank" rel="noopener noreferrer">A hidden breathing problem may be behind chronic fatigueâ€™s crushing exhaustion</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013240.htm" target="_blank" rel="noopener noreferrer">Astronomers shocked by mysterious gas found in deep space</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013238.htm" target="_blank" rel="noopener noreferrer">Supercomputer breakthrough exposes Enceladusâ€™s hidden ocean</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108012853.htm" target="_blank" rel="noopener noreferrer">COVID vaccine linked to fewer infections and allergies in kids with eczema</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010302.htm" target="_blank" rel="noopener noreferrer">Rare desert berry could transform diabetes treatment</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010248.htm" target="_blank" rel="noopener noreferrer">Scientists discover how hair cells can help heal skin faster</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111233952.htm" target="_blank" rel="noopener noreferrer">è„‘éƒ¨æ‰«ææ­ç¤ºäº†è¶³çƒè¿·çš„æ¿€æƒ…ä¸æ„¤æ€’çš„å“ªäº›ç§˜å¯†</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111010002.htm" target="_blank" rel="noopener noreferrer">Entangled spins give diamonds a quantum advantage</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111010000.htm" target="_blank" rel="noopener noreferrer">Tiny implant wipes out bladder cancer in 82% of patients</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111005944.htm" target="_blank" rel="noopener noreferrer">Clearing brain plaques isnâ€™t enough to heal Alzheimerâ€™s</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109032415.htm" target="_blank" rel="noopener noreferrer">Warm ocean beneath Saturnâ€™s icy moon Enceladus may be perfect for life</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013250.htm" target="_blank" rel="noopener noreferrer">New bacterial therapy destroys cancer without the immune system</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108083914.htm" target="_blank" rel="noopener noreferrer">DNAâ€™s hidden power could transform how we make medicines</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108083906.htm" target="_blank" rel="noopener noreferrer">New laser treatment could stop blindness before it starts</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010324.htm" target="_blank" rel="noopener noreferrer">Stanford makes stem cell transplants safer without chemo</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010322.htm" target="_blank" rel="noopener noreferrer">Scientists find hidden brain damage from a common pesticide</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010245.htm" target="_blank" rel="noopener noreferrer">The bright colors in your food may be harming your kids</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251106213557.htm" target="_blank" rel="noopener noreferrer">Mini llama proteins show promise for Alzheimerâ€™s treatment</a></li>
<li><a href="https://www.rna-seqblog.com/hydrarna-a-hybrid-architecture-based-full-length-rna-language-model/" target="_blank" rel="noopener noreferrer">HydraRNAâ€”â€”ä¸€ç§åŸºäºæ··åˆæ¶æ„çš„å…¨é•¿RNAè¯­è¨€æ¨¡å‹</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111005957.htm" target="_blank" rel="noopener noreferrer">This 14th century story fooled the world about the Black Death</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021056.htm" target="_blank" rel="noopener noreferrer">Hidden weakness makes prostate cancer self-destruct</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021043.htm" target="_blank" rel="noopener noreferrer">Vitamin D3 breakthrough halves risk of second heart attack</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013246.htm" target="_blank" rel="noopener noreferrer">AI unravels the hidden communication of gut microbes</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013244.htm" target="_blank" rel="noopener noreferrer">Doctors found a way to stop a deadly metformin reaction</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013236.htm" target="_blank" rel="noopener noreferrer">Dark energy might be changing and so is the Universe</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108083908.htm" target="_blank" rel="noopener noreferrer">â€œReally bizarreâ€ quantum discovery defies the rules of physics</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108014024.htm" target="_blank" rel="noopener noreferrer">Laser satellites expose a secret Antarctic carbon burst</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108014019.htm" target="_blank" rel="noopener noreferrer">MIT quantum breakthrough edges toward room-temp superconductors</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251106213552.htm" target="_blank" rel="noopener noreferrer">Common acne drug may protect against schizophrenia</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251112011841.htm" target="_blank" rel="noopener noreferrer">å¤©æ–‡å­¦å®¶éœ‡æƒŠäºä¸‰é¢—åœ°çƒå¤§å°çš„è¡Œæ˜Ÿå›´ç»•ä¸¤é¢—æ’æ˜Ÿè¿è¡Œ</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111005954.htm" target="_blank" rel="noopener noreferrer">Astronomers just solved the mystery of â€œimpossibleâ€ black holes</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251111005945.htm" target="_blank" rel="noopener noreferrer">Running on little sleep? Youâ€™re twice as likely to get hurt</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251110021046.htm" target="_blank" rel="noopener noreferrer">Surprising heart study finds daily coffee may cut AFib risk by 39%</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109032410.htm" target="_blank" rel="noopener noreferrer">Meet the desert survivor that grows faster the hotter it gets</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013254.htm" target="_blank" rel="noopener noreferrer">Life found in a place scientists thought impossible</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251109013248.htm" target="_blank" rel="noopener noreferrer">New online tool can predict how well blood pressure drugs will work</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108083904.htm" target="_blank" rel="noopener noreferrer">DNA in seawater reveals lost hammerhead sharks</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251108014022.htm" target="_blank" rel="noopener noreferrer">Einstein might have been wrong about black holes</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010326.htm" target="_blank" rel="noopener noreferrer">A hidden cellular cleanup trick could reverse aging</a></li>
<li><a href="https://www.sciencedaily.com/releases/2025/11/251107010250.htm" target="_blank" rel="noopener noreferrer">The hidden â€œBig Bangâ€ that decides how bowel cancer grows</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-12 21:41</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>